• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

低剂量阿托品在低近视人群中控制近视的每日及两日使用情况

The Daily and Two-Day Usage of Low-Dose Atropine on Myopic Control in a Low-Myopia Population.

作者信息

Lee Chia-Yi, Yang Shun-Fa, Huang Jing-Yang, Lian Ie-Bin, Chang Chao-Kai

机构信息

Institute of Medicine, Chung Shan Medical University, Taichung 40201, Taiwan.

Nobel Eye Institute, Taipei 10041, Taiwan.

出版信息

J Clin Med. 2025 May 15;14(10):3458. doi: 10.3390/jcm14103458.

DOI:10.3390/jcm14103458
PMID:40429453
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12112117/
Abstract

: The aim of this study was to evaluate the effectiveness of using low-dose atropine (ATR) at different instillation frequencies on myopia control in a low-myopia population. : A retrospective cohort study was conducted, and patients using 0.01% ATR and exhibiting a myopia degree ranging from +0.00 to -1.00 diopter (D) were included. A total of 32 and 26 eyes from 32 and 26 individuals were included in the daily group and two-day group, respectively. The main outcomes of this study are the progression of the spherical equivalent refraction (SER) and the elongation of the axial length (AXL). The Mann-Whitney U test and generalized linear model were used to perform the statistical analysis. : After a follow-up period of one year, the change in SER was similar between the daily group and two-day group (-0.24 ± 0.09 versus -0.26 ± 0.08, = 0.393). In addition, there was an insignificant difference in AXL elongation between the daily group and two-day group (0.09 ± 0.07 versus 0.10 ± 0.09, = 0.655). The trends observed in SER progression ( = 0.604) and AXL elongation ( = 0.779) were statistically identical between the daily group and the two-day group. : The results of the two-day use of low-dose ATR regarding SER and AXL control are similar to those with the daily use of low-dose ATR in children with low myopia.

摘要

本研究的目的是评估在低近视人群中,不同滴注频率使用低剂量阿托品(ATR)对控制近视的有效性。进行了一项回顾性队列研究,纳入使用0.01% ATR且近视度数在+0.00至-1.00屈光度(D)之间的患者。每日组和两日组分别纳入了32名个体的32只眼和26只眼。本研究的主要结果是等效球镜度(SER)的进展和眼轴长度(AXL)的延长。采用曼-惠特尼U检验和广义线性模型进行统计分析。随访一年后,每日组和两日组的SER变化相似(-0.24±0.09对-0.26±0.08,P = 0.393)。此外,每日组和两日组在AXL延长方面无显著差异(0.09±0.07对0.10±0.09,P = 0.655)。每日组和两日组在SER进展(P = 0.604)和AXL延长(P = 0.779)方面观察到的数据趋势在统计学上是相同的。低剂量ATR两日使用在控制SER和AXL方面的结果与低近视儿童每日使用低剂量ATR的结果相似。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/107f/12112117/690af06d8592/jcm-14-03458-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/107f/12112117/f94ef3450aaa/jcm-14-03458-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/107f/12112117/690af06d8592/jcm-14-03458-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/107f/12112117/f94ef3450aaa/jcm-14-03458-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/107f/12112117/690af06d8592/jcm-14-03458-g002.jpg

相似文献

1
The Daily and Two-Day Usage of Low-Dose Atropine on Myopic Control in a Low-Myopia Population.低剂量阿托品在低近视人群中控制近视的每日及两日使用情况
J Clin Med. 2025 May 15;14(10):3458. doi: 10.3390/jcm14103458.
2
The effect of defocus incorporated multiple segment spectacles' lenses combined with different concentrations atropine for myopia control.离焦型多焦点眼镜镜片联合不同浓度阿托品对近视控制的效果。
Sci Rep. 2025 Apr 10;15(1):12356. doi: 10.1038/s41598-025-91089-7.
3
The Effect of Myopic Control between the Dual-Focus Contact Lenses and High-Concentration Atropine in an Asian Population.双焦点隐形眼镜与高浓度阿托品对亚洲人群近视控制的效果。
Life (Basel). 2024 Jan 13;14(1):118. doi: 10.3390/life14010118.
4
Myopi-X lenses vs. low-dose atropine in myopia control: a Turkish retrospective study : Study design: retrospective observational study.Myopi-X镜片与低剂量阿托品用于近视控制:一项土耳其回顾性研究:研究设计:回顾性观察研究。
BMC Ophthalmol. 2025 Apr 17;25(1):220. doi: 10.1186/s12886-025-04009-8.
5
Interventions for myopia control in children: a living systematic review and network meta-analysis.儿童近视控制干预措施:一项实时系统评价和网状Meta分析
Cochrane Database Syst Rev. 2025 Feb 13;2(2):CD014758. doi: 10.1002/14651858.CD014758.pub3.
6
Interventions for myopia control in children: a living systematic review and network meta-analysis.儿童近视防控干预措施的系统评价和网络荟萃分析。
Cochrane Database Syst Rev. 2023 Feb 16;2(2):CD014758. doi: 10.1002/14651858.CD014758.pub2.
7
Interventions to slow progression of myopia in children.减缓儿童近视进展的干预措施。
Cochrane Database Syst Rev. 2020 Jan 13;1(1):CD004916. doi: 10.1002/14651858.CD004916.pub4.
8
Low-Dose 0.01% Atropine Eye Drops vs Placebo for Myopia Control: A Randomized Clinical Trial.低浓度 0.01%阿托品滴眼液与安慰剂治疗近视的随机临床试验。
JAMA Ophthalmol. 2023 Aug 1;141(8):756-765. doi: 10.1001/jamaophthalmol.2023.2855.
9
Prevention of myopia shift and myopia onset using 0.01% atropine in premyopic children - a prospective, randomized, double-masked, and crossover trial.应用 0.01%阿托品预防近视儿童近视进展和近视发生:一项前瞻性、随机、双盲、交叉试验。
Eur J Pediatr. 2023 Jun;182(6):2597-2606. doi: 10.1007/s00431-023-04921-5. Epub 2023 Mar 22.
10
0.05% atropine on control of myopia progression in Chinese school children: a randomized 3-year clinical trial.0.05%阿托品对中国学龄儿童近视进展的控制:一项为期3年的随机临床试验。
Int J Ophthalmol. 2023 Jun 18;16(6):939-946. doi: 10.18240/ijo.2023.06.17. eCollection 2023.

本文引用的文献

1
Digital Screen Time and Myopia: A Systematic Review and Dose-Response Meta-Analysis.数字屏幕使用时间与近视:一项系统评价和剂量反应荟萃分析
JAMA Netw Open. 2025 Feb 3;8(2):e2460026. doi: 10.1001/jamanetworkopen.2024.60026.
2
Physiological growth of ocular axial length among Chinese children and teenagers: A 6-year cohort study.中国儿童和青少年眼轴长度的生理性生长:一项6年队列研究。
PLoS One. 2025 Jan 24;20(1):e0317756. doi: 10.1371/journal.pone.0317756. eCollection 2025.
3
Context of Atropine Adherence in Preschool Children with Early-Onset Myopia: A Qualitative Study.
学龄前儿童早发性近视中阿托品依从性的背景:一项定性研究。
Children (Basel). 2024 Sep 5;11(9):1087. doi: 10.3390/children11091087.
4
The Effect of Alternating Monocular Instillation of 0.125% Atropine in Korean Children with Progressive Myopia.0.125%阿托品交替单眼滴眼对韩国进行性近视儿童的影响。
J Clin Med. 2024 Aug 23;13(17):5003. doi: 10.3390/jcm13175003.
5
Myopia progression following 0.01% atropine cessation in Australian children: Findings from the Western Australia - Atropine for the Treatment of Myopia (WA-ATOM) study.澳大利亚儿童停止使用 0.01%阿托品后近视进展情况:西澳大利亚州-阿托品治疗近视(WA-ATOM)研究结果。
Clin Exp Ophthalmol. 2024 Jul;52(5):507-515. doi: 10.1111/ceo.14368. Epub 2024 Feb 23.
6
Myopia outcome study of atropine in children: Two-year result of daily 0.01% atropine in a European population.儿童阿托品近视研究:欧洲人群中每日使用 0.01%阿托品两年的结果。
Acta Ophthalmol. 2024 May;102(3):e245-e256. doi: 10.1111/aos.15761. Epub 2023 Sep 11.
7
Treatment of Myopia with Atropine 0.125% Once Every Night Compared with Atropine 0.125% Every Other Night: A Pilot Study.每晚一次使用0.125%阿托品与隔晚一次使用0.125%阿托品治疗近视的初步研究。
J Clin Med. 2023 Aug 10;12(16):5220. doi: 10.3390/jcm12165220.
8
Low-Dose 0.01% Atropine Eye Drops vs Placebo for Myopia Control: A Randomized Clinical Trial.低浓度 0.01%阿托品滴眼液与安慰剂治疗近视的随机临床试验。
JAMA Ophthalmol. 2023 Aug 1;141(8):756-765. doi: 10.1001/jamaophthalmol.2023.2855.
9
Efficacy and Safety of 0.01% and 0.02% Atropine for the Treatment of Pediatric Myopia Progression Over 3 Years: A Randomized Clinical Trial.0.01%和0.02%阿托品治疗儿童近视进展3年的疗效和安全性:一项随机临床试验
JAMA Ophthalmol. 2023 Oct 1;141(10):990-999. doi: 10.1001/jamaophthalmol.2023.2097.
10
Efficacy and safety of atropine in myopic children: A meta-analysis of randomized controlled trials.阿托品治疗近视儿童的疗效和安全性:一项随机对照试验的荟萃分析。
J Fr Ophtalmol. 2023 Oct;46(8):929-940. doi: 10.1016/j.jfo.2023.01.030. Epub 2023 May 3.